Dr. Ailen Magdevis Sell Gramatges, MD

Dr. Sell Gramatges practices at Baptist Health Baptist Hospital in Miami, Florida, part of Baptist Health South Florida.

Dr. Sell Gramatges' NPI, 1871903500, was assigned on May 2, 2014. Dr. Sell Gramatges graduated from Universidad Superior de Ciencias Medicas in 2007. Dr. Sell Gramatges holds Florida license ME131205.

Dr. Sell Gramatges' primary practice is Baptist Health Baptist Hospital, at 8900 N Kendall Dr, Miami, FL 33176 in Miami-Dade County. The practice phone is (786) 596-1960.

Dr. Sell Gramatges' primary practice is Baptist Health Baptist Hospital in Miami, Florida, part of Baptist Health South Florida. Dr. Sell Gramatges is also affiliated with Baptist Health Doctors Hospital. The medical group on file is Baptist Health Medical Group. Dmand AI also links Dr. Sell Gramatges to 1 more breast imaging center, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sell Gramatges practices, 3 sites in all. Vendor and product names are available with a free account.

Hospitalist is Dr. Sell Gramatges' primary specialty in the NPI Registry, under taxonomy code 208M00000X. Dr. Sell Gramatges is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Sell Gramatges' licenses on file in 2 states: Florida and Pennsylvania.

Dmand AI lists bile duct problems, cellulitis, circulatory problems in extremities, congestive heart failure, electrolyte disorders, gastrointestinal bleeding, gastrointestinal inflammation and lung disease: COPD, asthma or bronchitis among the conditions Dr. Sell Gramatges treats.

CMS data shows 538 Medicare services from Dr. Sell Gramatges across 5 procedure codes in 2024, for 175 Medicare patients. Medicare paid $48,045 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 175 Medicare patients who saw Dr. Sell Gramatges in 2024. The largest group is 75 to 84, with 72 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 42% are also on Medicaid. Their average risk score is 3.06, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Sell Gramatges' median patient age at 67, with 53% women.

In 2024, Dr. Sell Gramatges wrote 326 Medicare Part D claims for 123 patients. 89% of them were for generic drugs. CMS names the drug for 67 of them, across 4 drugs with 11 or more claims each, at $189 in total drug cost. In 2023, CMS named 36 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 99 out of 100 for Dr. Sell Gramatges for performance year 2024, reported through an alternative payment model (APM). Dr. Sell Gramatges accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 38 general payments to Dr. Sell Gramatges from 12 drug and device companies from 2017 to 2023. Food and beverage make up the largest share, 100% of the total. Pfizer Inc. paid the most, $492.

Dr. Sell Gramatges graduated from Universidad Superior de Ciencias Medicas in 2007.

Dr. Sell Gramatges is in network with 9 carriers, including United Healthcare, Elevance and Aspirus Health Plan. PPO plans come from the most carriers, 4. Check the plan with the practice before a visit.